Phase I Dose-Escalation Study of Weekly Paclitaxel and Cisplatin Followed by Radical Hysterectomy in Stages IB2 and IIA2 Cervical Cancer-Reference-Cited by-同舟云学术

Phase I Dose-Escalation Study of Weekly Paclitaxel and Cisplatin Followed by Radical Hysterectomy in Stages IB2 and IIA2 Cervical Cancer

Published:2017-06 Issue:3 Volume:40 Page:241-249
ISSN:0277-3732
Container-title:American Journal of Clinical Oncology
language:en
Short-container-title:

Author:

Chou Hung-Hsueh,Huang Huei-Jean,Lin Hao,Yang Lan-Yan,Hsueh Swei,Liu Feng-Yuan,Liou Yen-Lyin,Liou Jui-Der,Chen Min-Yu,Chao Angel,Lin Gigin,Chang Ting-Chang,Lai Chyong-Huey

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Oncology

Reference36 articles.

1. Global cancer statistics;Jemal;CA Cancer J Clin,2011

2. Cervical cancer;Waggoner;Lancet,2003

3. Preoperative prognostic variables and the impact of postoperative adjuvant therapy on the outcomes of Stage IB or II cervical carcinoma patients with or without pelvic lymph node metastases: an analysis of 891 cases;Lai;Cancer,1999

4. Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study;Delgado;Gynecol Oncol,1990

5. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis;Green;Lancet,2001

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neoadjuvant chemotherapy prior to radical hysterectomy in locally advanced cervical cancer: a systematic review and meta-analysis;International Journal of Gynecologic Cancer;2023-11-27

2. TUSC3 inhibits cell proliferation and invasion in cervical squamous cell carcinoma via suppression of the AKT signalling pathway;Journal of Cellular and Molecular Medicine;2022-02-09

3. Comparison of survival outcomes between laparoscopic surgery and abdominal surgery for radical hysterectomy as primary treatment in patients with stage IB2 / IIA2 cervical cancer;Journal of Obstetrics and Gynaecology Research;2021-02